Sustained Complete Molecular Response to Imatinib in Chronic Myeloid Leukemia (CML): a Target Worth Aiming and Achieving?.
暂无分享,去创建一个
A. Verma | H. Kantarjian | J. Cortes | S. Verstovsek | T. Kadia | E. Jabbour | S. O'brien | J. Shan | M. Rios | D. Verma | Jenny Shan